PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'2nd Department of Cardiology, Attikon Hospital, National and Kapodistrian University of Athens, Medical School, 12462, Athens, Greece. Electronic address: ignoik@gmail.com.\', \'2nd Department of Cardiology, Attikon Hospital, National and Kapodistrian University of Athens, Medical School, 12462, Athens, Greece.\', \'4th Department of Internal Medicine, Attikon Hospital, National and Kapodistrian University of Athens, Medical School, 12462, Athens, Greece.\', \'2nd Department of Internal Medicine, Research Unit and Diabetes Center, Attikon Hospital, National and Kapodistrian University of Athens, Medical School, 12462, Athens, Greece.\', \'Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, 15741, Athens, Greece.\', \'Department of Biochemistry and Biotechnology, University of Thessaly, 41500, Larissa, Greece.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0278-6915(20)30584-610.1016/j.fct.2020.111694
?:doi
?:hasPublicationType
?:journal
  • Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
is ?:pmid of
?:pmid
?:pmid
  • 32822775
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Tocilizumab improves oxidative stress and endothelial glycocalyx: A mechanism that may explain the effects of biological treatment on COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all